Lung cancer patients with addiction history face hidden hurdles – study aims to uncover them
NCT ID NCT07186699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study interviews 45 adults with non-small cell lung cancer who also had a past alcohol or substance use disorder (other than tobacco). Researchers want to learn what social factors help or hinder detection and treatment of their cancer. The goal is to identify ways to improve care for this group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors and hospitals better support lung cancer patients who have a history of substance use, potentially improving their access to timely treatment.
- What could go wrong
- This is a small, early-stage interview study with only 45 people. It is not testing a treatment, so it will not directly change patient outcomes. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Los Angeles General Medical Center
RECRUITINGLos Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple assessment help older lung cancer patients tolerate chemo better?
- Could lung cancer patients get immunotherapy less often?
- New combo aims to stall lung Cancer's spread
- New tool may help older cancer patients avoid harsh chemo side effects
- DNA vaccine aims to train immune system against lung cancer
- Lung cancer vaccine shows promise in early prevention trial